Midday movers: Victoria's Secret, Nordstrom fall; OneSpan, Novo Nordisk rise

Go back to Midday movers: Victoria's Secret, Nordstrom fall; OneSpan, Novo Nordisk rise

Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK1,054 at TD Cowen

March 11, 2024 2:03 PM EDT

TD Cowen analyst Steve Scala raised the price target on Novo Nordisk (NOVOB:DC) (NYSE: NVO) to DKK1,054.00 (from DKK925.00) while maintaining a Outperform rating.

The analyst comments "Novo announced FDA approval of the expanded label for Wegovy, now indicated to reduce CV risk in people with both obesity and CVD based on data from SELECT. Though these data are widely appreciated by specialists after... More

Kroger (KR) PT Raised to $58 at BMO Capital

March 11, 2024 3:59 AM EDT

BMO Capital analyst Kelly Bania raised the price target on Kroger (NYSE: KR) to $58.00 (from $46.00) while maintaining a Market Perform rating.

The analyst comments "KR's F4Q24 performance was solid and guidance suggests environment remains stable, which we believe combined with positive... More

Kroger (KR) PT Raised to $70 at BofA Securities

March 8, 2024 9:35 AM EST

BofA Securities analyst Robert Ohmes raised the price target on Kroger (NYSE: KR) to $70.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "Post KR's strong F4Q earnings, we reiterate our Buy rating. We raise our PO to $70 (was... More

Victoria's Secret (VSCO) PT Lowered to $27 at Jefferies

March 7, 2024 4:30 PM EST

Jefferies analyst Corey Tarlowe lowered the price target on Victoria's Secret (NYSE: VSCO) to $27.00 (from $35.00) while maintaining a Buy rating.

The analyst comments "VSCO reported 4Q results within its guided range. The top line came in just shy of expectations, but better-than-expected gross... More

Stifel Out Positive on Rivian Automotive Inc (RIVN)

March 7, 2024 4:06 PM EST

Stifel analyst Stephen Gengaro reiterated a Buy rating and $18.00 price target on Rivian Automotive Inc (NASDAQ: RIVN).

The analyst comments "Rivian unveiled its R2 mid-size SUV platform earlier today, expected to start at about $45,000 and scheduled for initial production in 1H26. Key positives from the launch... More

Jefferies starts Viking Therapeutics (VKTX) at buy on 'scarcity value'

March 7, 2024 1:59 PM EST

Jefferies initiated Viking Therapeutics (NASDAQ: VKTX) with a Buy rating and $110 per share price target in a note Thursday, telling investors the company is a strong mid-stage obesity player with scarcity value.

VKTX is developing subQ/oral VK2735 (GLP-1/GIP) for obesity,... More